WHO Report Shows Alarming Increase in Youth E-cigarette Use

Regulations by 2FIRSTS.ai
May.15.2024
WHO Report Shows Alarming Increase in Youth E-cigarette Use
WHO report raises concerns as youth e-cigarette users surpass smokers. Action called to regulate e-cigarette marketing targeting young people.

According to a report from VapingPost on May 14th, the World Health Organization (WHO) recently released a report showing that the number of adolescent e-cigarette users has surpassed smokers. The report expresses concern about this phenomenon.

WHO Report Shows Alarming Increase in Youth E-cigarette Use

 

The survey, entitled "Health Behavior in School-aged Children" (HBSC), aims to monitor substance use among 11, 13, and 15-year-old adolescents from 44 countries and regions in Europe, Central Asia, and Canada, including smoking, e-cigarette use, alcohol, and cannabis. This survey is conducted every four years. The latest survey data is from the period of 2021 to 2022, and the results show that e-cigarette use has surpassed traditional tobacco use.

 

According to the study, among 11-year-old teenagers, the proportion who have smoked at least one cigarette in the past 30 days is 2%, while the proportion who have used an e-cigarette is 2.5%. For 13-year-olds, these proportions are 5.5% and 9%, and for 15-year-olds, they are 15% and 19.5% respectively.

 

The World Health Organization has expressed concern over this situation, calling for special attention to the issue of e-cigarettes and recommending a "ban or strong regulation" on their use, as e-cigarettes are primarily marketed towards youth. The organization also proposes taking action by "banning advertisements, promotions, and various flavored e-liquids, to reduce the accessibility of e-cigarettes to young people.

 

The World Health Organization maintains its stance against e-cigarettes and has outlined a precise increase in the number of young people using e-cigarettes. However, their description of regular smokers is more vague, only noting a decrease in the "number of smokers in people's lives." To obtain specific data, one must look at the report's appendix and compare it to the previous survey. The appendix indicates that the percentage of 15-year-olds smoking has decreased from 28% in 2018 to 25% in 2022, a decrease of nearly 11%.

 

Some observers criticize a recent report that despite numerous scientific studies verifying that e-cigarettes pose less harm to health than traditional tobacco, the World Health Organization has chosen to condemn e-cigarettes. The rise of e-cigarettes may not only lead more young people to nicotine through e-cigarettes instead of traditional tobacco, but also potentially decrease the number of young people who have tried smoking. In other words, young people are increasingly leaning towards choosing relatively healthy options when experimenting with substances, and the WHO should welcome this result rather than criticize it.

 

The World Health Organization strongly opposes e-cigarettes, believing they are primarily designed to entice young people into addiction to nicotine products. The World Health Organization encourages countries looking to combat smoking to support alternative nicotine delivery methods.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Juul Labs displayed its JUUL2 e-cigarette system alongside existing products, age-verification messaging and mobile coupons, 2Firsts observed. The JUUL2 device and Virginia Tobacco and Polar Menthol pods received FDA marketing authorization in August 2026. Booth materials highlighted longer battery life, greater e-liquid capacity and connected-device features. A TruAge sign and a mobile coupon presentation also featured at the booth, with weekly offers available to age-verified adult nicotine consumers at participating retailers.
EXPO
Oct.09
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia's digital labeling regime for reusable e-cigarettes and similar personal vaping devices entered its first mandatory phase in September 2026. From September 1, manufacturers, importers and other market participants must register with the national Chestny ZNAK tracking system. From December 1, newly manufactured and imported covered devices will be required to carry digital identification codes and be reported as entering circulation. Russia has also issued new operational guidance for imports, marking the transition from a voluntary pilot to phased mandatory implementation.
Sep.15
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
A 2Firsts analysis of Virginia's liquid nicotine and vapor product certification directory identified 213 product records from 15 manufacturers. Companies associated with BAT, Altria, Imperial Brands, JTI and JUUL account for 127 entries. The directory also includes independent brands CrossBar 20K, Loon and Breeze. CrossBar advertises a 13mL disposable capable of up to 20,000 puffs, while Loon has 16 disposable entries featuring fruit, cooling and beverage-related flavors. Of all records, 120 are labeled as under FDA PMTA review. Virginia introduced revised penalties on October 1, 2026, including a minimum first-violation civil penalty of $5,000 per unlisted product, alongside new retail tobacco permitting requirements.
Regulations
Oct.30
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09